FDA Approves First Drug for Moderate and Severe Eczema Cases

U.S. regulators have approved the first powerful, injected medicine to treat serious cases of the skin condition eczema.

The Food and Drug Administration on Tuesday approved Dupixent for moderate or severe eczema, which causes red, fiercely itchy rashes on the face, arms and legs.

In three studies of the drug including a total of 2,119 participants, one-third to two-thirds achieved clear or nearly clear skin after 16 weeks of treatment. About four in 10 had itching decrease

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *